Christian Kvikne Dotterud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christian Kvikne Dotterud has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ola Storrø
Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway
4 shared publications - Roar Johnsen
Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway
4 shared publications - Torbjørn Øien
Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway
4 shared publications - Melanie Rae Simpson
Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim
2 shared publications - Jon A Jenssen
Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, N-7489 Trondheim, Norway
1 shared publication - Marit Saunes
Department of Dermatology, St. Olavs Hospital, Trondheim University Hospital
1 shared publication
Latest Publications
- Open Access
- 1 August 2015
- Published by Springer Nature in BMC Dermatology
- Vol. 15 (1) , 1-8
Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial
Perinatal probiotics supplementation has been shown to be effective in the primary prevention of atopic dermatitis (AD) in early childhood, although the long term effects of probiotics on AD and other allergic diseases is less certain. We have previously reported a significant reduction in the cumulative incidence of AD at 2 years after maternal probiotic supplementation. In this study we present the effects of perinatal probiotics given to women from a general population on allergy related diseases in their offspring at 6 years. Four hundred and fifteen pregnant women were randomised to receive probiotic or placebo milk in a double-blinded trial from 36 week gestation until 3 months postpartum. Probiotic milk contained Lactobacillus rhamnosos GG, L. acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12. At 6 years, children were re-assessed for AD, atopic sensitisation, asthma and allergic rhinoconjunctivitis (ARC). At 6 years, 81 and 82 children were assessed for AD in the probiotic and placebo groups, respectively. In a multiple imputation analysis, there was as trend towards a lower cumulative incidence of AD in the probiotic group compared to the placebo group (OR 0.64, 95 % CI 0.39-1.07, p = 0.086; NNT = 10). This finding was statistically significantly in the complete case analysis (OR 0.48, 95 % CI 0.25-0.92, p = 0.027, NNT = 6). The prevalence of asthma and atopic sensitisation, and the cumulative incidence of ARC were not significantly affected by the probiotic regime at 6 years of age. Maternal probiotic ingestion alone may be sufficient for long term reduction in the cumulative incidence of AD, but not other allergy related diseases. ClinicalTrials.gov identifier: NCT00159523
- 1 August 2015
- Published by Springer Nature in BMC Dermatology
- Vol. 15 (1) , 1-8
Open AccessPerinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial
Perinatal probiotics supplementation has been shown to be effective in the primary prevention of atopic dermatitis (AD) in early childhood, although the long term effects of probiotics on AD and other allergic diseases is less certain. We have previously reported a significant reduction in the cumulative incidence of AD at 2 years after maternal probiotic supplementation. In this study we present the effects of perinatal probiotics given to women from a general population on allergy related diseases in their offspring at 6 years. Four hundred and fifteen pregnant women were randomised to receive probiotic or placebo milk in a double-blinded trial from 36 week gestation until 3 months postpartum. Probiotic milk contained Lactobacillus rhamnosos GG, L. acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12. At 6 years, children were re-assessed for AD, atopic sensitisation, asthma and allergic rhinoconjunctivitis (ARC). At 6 years, 81 and 82 children were assessed for AD in the probiotic and placebo groups, respectively. In a multiple imputation analysis, there was as trend towards a lower cumulative incidence of AD in the probiotic group compared to the placebo group (OR 0.64, 95 % CI 0.39-1.07, p = 0.086; NNT = 10). This finding was statistically significantly in the complete case analysis (OR 0.48, 95 % CI 0.25-0.92, p = 0.027, NNT = 6). The prevalence of asthma and atopic sensitisation, and the cumulative incidence of ARC were not significantly affected by the probiotic regime at 6 years of age. Maternal probiotic ingestion alone may be sufficient for long term reduction in the cumulative incidence of AD, but not other allergy related diseases. ClinicalTrials.gov identifier: NCT00159523
- Open Access
- 8 February 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 123
The impact of pre- and postnatal exposures on allergy related diseases in childhood: a controlled multicentre intervention study in primary health care
Environmental factors such as tobacco exposure, indoor climate and diet are known to be involved in the development of allergy related diseases. The aim was to determine the impact of altered exposure to these factors during pregnancy and infancy on the incidence of allergy related diseases at 2 years of age.
- 8 February 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 123
Open AccessThe impact of pre- and postnatal exposures on allergy related diseases in childhood: a controlled multicentre intervention study in primary health care
Environmental factors such as tobacco exposure, indoor climate and diet are known to be involved in the development of allergy related diseases. The aim was to determine the impact of altered exposure to these factors during pregnancy and infancy on the incidence of allergy related diseases at 2 years of age.
- Open Access
- 24 October 2012
- Published by Springer Nature in BMC Pediatrics
- Vol. 12 (1) , 168
Early eczema and the risk of childhood asthma: a prospective, population-based study
Severe eczema in young children is associated with an increased risk of developing asthma and rhino-conjunctivitis. In the general population, however, most cases of eczema are mild to moderate. In an unselected cohort, we studied the risk of current asthma and the co-existence of allergy-related diseases at 6 years of age among children with and without eczema at 2 years of age.
- 24 October 2012
- Published by Springer Nature in BMC Pediatrics
- Vol. 12 (1) , 168
Open AccessEarly eczema and the risk of childhood asthma: a prospective, population-based study
Severe eczema in young children is associated with an increased risk of developing asthma and rhino-conjunctivitis. In the general population, however, most cases of eczema are mild to moderate. In an unselected cohort, we studied the risk of current asthma and the co-existence of allergy-related diseases at 6 years of age among children with and without eczema at 2 years of age.
- Open Access
- 28 July 2010
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 443
A primary health-care intervention on pre- and postnatal risk factor behavior to prevent childhood allergy. The Prevention of Allergy among Children in Trondheim (PACT) study
This study aimed to evaluate the impact of a primary prevention intervention program on risk behavior for allergic diseases among children up to 2 years of age. The setting was in ordinary pre- and postnatal primary health care in Trondheim, Norway.
- 28 July 2010
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 443
Open AccessA primary health-care intervention on pre- and postnatal risk factor behavior to prevent childhood allergy. The Prevention of Allergy among Children in Trondheim (PACT) study
This study aimed to evaluate the impact of a primary prevention intervention program on risk behavior for allergic diseases among children up to 2 years of age. The setting was in ordinary pre- and postnatal primary health care in Trondheim, Norway.